FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002731775> ?p ?o ?g. }

• W2002731775 endingPage "41552" @default.
• W2002731775 startingPage "41546" @default.
• W2002731775 abstract "Although mimics of human tumor antigens are effective immunogens to overcome host unresponsiveness to the nominal antigen, the structural basis of this mimicry remains poorly defined. Therefore, in this study we have characterized the structural basis of the human high molecular weight-melanoma-associated antigen (HMW-MAA) mimicry by the mouse anti-idiotypic (anti-id) monoclonal antibody (mAb) MK2-23. Using x-ray crystallography, we have characterized the three-dimensional structure of the anti-id mAb MK2-23 Fab′ and shown that its heavy chain complementarity-determining region (CDR3) (H3) and its light chain CDR1 (L1) are closely associated. These moieties are the source of HMW-MAA mimicry, since they display partial amino acid sequence homology along with a similar structural fold with the HMW-MAA core protein. Furthermore, a 15-residue peptide comprising the H3 loop of anti-id mAb MK2-23 demonstrates HMW-MAA-like in vitro and in vivo reactivity. This peptide in conjunction with the structural data will facilitate the characterization of the effect of the degree of antigen mimicry on the induction of a self-antigen-specific immune response by a mimic. Although mimics of human tumor antigens are effective immunogens to overcome host unresponsiveness to the nominal antigen, the structural basis of this mimicry remains poorly defined. Therefore, in this study we have characterized the structural basis of the human high molecular weight-melanoma-associated antigen (HMW-MAA) mimicry by the mouse anti-idiotypic (anti-id) monoclonal antibody (mAb) MK2-23. Using x-ray crystallography, we have characterized the three-dimensional structure of the anti-id mAb MK2-23 Fab′ and shown that its heavy chain complementarity-determining region (CDR3) (H3) and its light chain CDR1 (L1) are closely associated. These moieties are the source of HMW-MAA mimicry, since they display partial amino acid sequence homology along with a similar structural fold with the HMW-MAA core protein. Furthermore, a 15-residue peptide comprising the H3 loop of anti-id mAb MK2-23 demonstrates HMW-MAA-like in vitro and in vivo reactivity. This peptide in conjunction with the structural data will facilitate the characterization of the effect of the degree of antigen mimicry on the induction of a self-antigen-specific immune response by a mimic. Antigen mimicry has been implicated in the pathogenesis of several pathophysiological conditions such as viral immune evasion (1Wucherpfennig K.W. Strominger J.L. Cell. 1995; 80: 695-705Abstract Full Text PDF PubMed Scopus (1266) Google Scholar, 2Alcami A. Nat. Rev. Immunol. 2003; 3: 36-50Crossref PubMed Scopus (435) Google Scholar, 3Bernet J. Mullick J. Singh A.K. Sahu A. J. Biosci. 2003; 28: 249-264Crossref PubMed Scopus (70) Google Scholar) and autoimmunity (4Kohm A.P. Fuller K.G. Miller S.D. Trends Microbiol. 2003; 11: 101-105Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar, 5Ang C.W. Jacobs B.C. Laman J.D. Trends Immunol. 2004; 25: 61-66Abstract Full Text Full Text PDF PubMed Scopus (259) Google Scholar, 6McClain M.T. Heinlen L.D. Dennis G.J. Roebuck J. Harley J.B. James J.A. Nat. Med. 2005; 11: 85-89Crossref PubMed Scopus (316) Google Scholar, 7McGuire K.L. Holmes D.S. Trends Immunol. 2005; 26: 367-372Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar). In these situations, the structurally similar foreign moieties either interfere with the normal biological functions mediated by their nominal counterparts or elicit unwanted immune responses against the host antigens. The consequences sometimes can be quite detrimental. Nevertheless, in the case of autoimmune responses mediated by molecular mimicry, an intriguing finding is the restriction of the damage to an organ or a tissue. This pattern is distinct from the general immune hyper-responsiveness caused by suppression of the regulatory arm of the immune system, such as cytotoxic T lymphocyte antigen-4 (CTLA-4) blockade (8Chikuma S. Bluestone J.A. Immunol. Res. 2003; 28: 241-253Crossref PubMed Scopus (69) Google Scholar, 9von Boehmer H. Nat. Immunol. 2005; 6: 338-344Crossref PubMed Scopus (894) Google Scholar). The potential ability of molecular mimicry to target a specific host antigen has provided the rationale for its use to elicit and/or enhance an immune response against human tumor antigens that are mostly non-mutated self-antigens and therefore poorly or non-immunogenic in patients (for review, see Refs. 10Wang X. Luo W. Foon K.A. Ferrone S. Cancer Chemother. Biol. Response Modif. 2001; 19: 309-326PubMed Google Scholar and 11Luo W. Hsu J.C. Kieber-Emmons T. Wang X. Ferrone S. Cancer Chemother. Biol. Response Modif. 2005; 22: 769-787Crossref PubMed Google Scholar). Various types of tumor antigen mimics have been identified (for review, see Ref. 11Luo W. Hsu J.C. Kieber-Emmons T. Wang X. Ferrone S. Cancer Chemother. Biol. Response Modif. 2005; 22: 769-787Crossref PubMed Google Scholar). Among them the most extensively utilized is represented by antiidiotypic (anti-id) 4The abbreviations used are: anti-idanti-idiotypicCDRcomplementarity-determining regionCSPGchondroitin sulfate proteoglycanFACSfluorescence-activated cell sortingH3heavy chain CDR3HMW-MAAhuman high molecular weight-melanoma-associated antigenL1light chain CDR1mAbmonoclonal antibodyPDBProtein Data BankELISAenzyme-linked immunosorbent assayaaamino acid(s)r.m.s.d.root mean square deviation.4The abbreviations used are: anti-idanti-idiotypicCDRcomplementarity-determining regionCSPGchondroitin sulfate proteoglycanFACSfluorescence-activated cell sortingH3heavy chain CDR3HMW-MAAhuman high molecular weight-melanoma-associated antigenL1light chain CDR1mAbmonoclonal antibodyPDBProtein Data BankELISAenzyme-linked immunosorbent assayaaamino acid(s)r.m.s.d.root mean square deviation. monoclonal antibodies (mAb), which have been developed in several human tumor antigen systems (for review, see Refs. 10Wang X. Luo W. Foon K.A. Ferrone S. Cancer Chemother. Biol. Response Modif. 2001; 19: 309-326PubMed Google Scholar and 11Luo W. Hsu J.C. Kieber-Emmons T. Wang X. Ferrone S. Cancer Chemother. Biol. Response Modif. 2005; 22: 769-787Crossref PubMed Google Scholar). Anti-id mAb markedly differ in their immunogenicity as measured by their ability to elicit a humoral immune response to the corresponding self-tumor antigen. The cause of this variability is not known. The lack of this information reflects, at least in part, the limited knowledge about the structural basis of antigen mimicry by anti-id antibodies and about the relationship between the extent of antigen mimicry and ability of a mimic to overcome unresponsiveness to a self-tumor antigen. Since this knowledge may improve the design of tumor vaccines, in the present study we have investigated the structural basis of human high molecular weight-melanoma associated antigen (HMW-MAA) (12Campoli M.R. Chang C.C. Kageshita T. Wang X. McCarthy J.B. Ferrone S. Crit. Rev. Immunol. 2004; 24: 267-296Crossref PubMed Scopus (148) Google Scholar) mimicry by the mouse anti-id mAb MK2-23 (13Kusama M. Kageshita T. Chen Z.J. Ferrone S. J. Immunol. 1989; 143: 3844-3852PubMed Google Scholar). The latter anti-id mAb was derived from a mouse immunized with the HMW-MAA-specific idiotypic mAb 763.74 (13Kusama M. Kageshita T. Chen Z.J. Ferrone S. J. Immunol. 1989; 143: 3844-3852PubMed Google Scholar). This antigen system was selected for our studies, since anti-id mAb MK2-23 has been found to elicit HMW-MAA-specific antibodies in mice and rabbits (14Chen Z.J. Yang H. Ferrone S. J. Immunol. 1991; 147: 1082-1090PubMed Google Scholar, 15Chen Z.J. Yang H. Liu C.C. Hirai S. Ferrone S. Cancer Res. 1993; 53: 112-119PubMed Google Scholar), both of which express orthologs of human HMW-MAA constitutively (16Schlingemann R.O. Rietveld F.J. de Waal R.M. Ferrone S. Ruiter D.J. Am. J. Pathol. 1990; 136: 1393-1405PubMed Google Scholar, 17Diers-Fenger M. Kirchhoff F. Kettenmann H. Levine J.M. Trotter J. Glia. 2001; 34: 213-228Crossref PubMed Scopus (113) Google Scholar). In addition, anti-id mAb MK2-23 was able to induce HMW-MAA-specific humoral responses in patients with melanoma (18Mittelman A. Chen Z.J. Yang H. Wong G.Y. Ferrone S. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 466-470Crossref PubMed Scopus (214) Google Scholar, 19Mittelman A. Chen G.Z.J. Wong G.Y. Liu C. Hirai S. Ferrone S. Clin. Cancer Res. 1995; 1: 705-713PubMed Google Scholar). This immune response appears to be clinically relevant, since it was associated with regression of metastases in a few patients (20Mittelman A. Chen Z.J. Liu C.C. Hirai S. Ferrone S. Cancer Res. 1994; 54: 415-421PubMed Google Scholar) and with a statistically significant survival prolongation (18Mittelman A. Chen Z.J. Yang H. Wong G.Y. Ferrone S. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 466-470Crossref PubMed Scopus (214) Google Scholar, 19Mittelman A. Chen G.Z.J. Wong G.Y. Liu C. Hirai S. Ferrone S. Clin. Cancer Res. 1995; 1: 705-713PubMed Google Scholar). The elicited HMW-MAA-specific antibodies, or anti-anti-id antibodies, were also found to inhibit the binding of mAb 763.74 (21Giacomini P. Ng A.K. Kantor R.R.S. Natali P.G. Ferrone S. Cancer Res. 1983; 43: 3586-3590PubMed Google Scholar) to HMW-MAA in vitro (14Chen Z.J. Yang H. Ferrone S. J. Immunol. 1991; 147: 1082-1090PubMed Google Scholar, 15Chen Z.J. Yang H. Liu C.C. Hirai S. Ferrone S. Cancer Res. 1993; 53: 112-119PubMed Google Scholar, 18Mittelman A. Chen Z.J. Yang H. Wong G.Y. Ferrone S. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 466-470Crossref PubMed Scopus (214) Google Scholar), suggesting that structural rather than functional homology underlies the mAb 763.74 defined HMW-MAA epitope mimicry by the anti-id mAb MK2-23. anti-idiotypic complementarity-determining region chondroitin sulfate proteoglycan fluorescence-activated cell sorting heavy chain CDR3 human high molecular weight-melanoma-associated antigen light chain CDR1 monoclonal antibody Protein Data Bank enzyme-linked immunosorbent assay amino acid(s) root mean square deviation. anti-idiotypic complementarity-determining region chondroitin sulfate proteoglycan fluorescence-activated cell sorting heavy chain CDR3 human high molecular weight-melanoma-associated antigen light chain CDR1 monoclonal antibody Protein Data Bank enzyme-linked immunosorbent assay amino acid(s) root mean square deviation. Using x-ray crystallography and immunological studies, we have found that the complementarity determining region 3 (CDR3) of the anti-id mAb MK2-23 heavy chain plays an important role in the three-dimensional structural basis of HMW-MAA mimicry by anti-id mAb MK2-23. Purification of Anti-id mAb MK2-23 F(ab′)2 Fragments—F(ab′)2 fragments were generated by digesting with immobilized pepsin (Pierce) mouse mAb IgG1 MK2-23 (14Chen Z.J. Yang H. Ferrone S. J. Immunol. 1991; 147: 1082-1090PubMed Google Scholar), which was purified from ascites by protein A chromatography (Bio-Rad). High purity mAb MK2-23 F(ab′)2 fragments were obtained by sequential protein A column and S-200 gel filtration chromatography. Peak S-200 fractions were pooled and concentrated to 7.9-10 mg/ml in low salt phosphate buffer (50 mm KH2PO4, 10 mm NaCl, pH 7.4). Purified F(ab′)2 fragment preparations were preincubated at room temperature with 5 mm dithiothreitol at pH 5.5 for 1.5 h, yielding monomeric Fab′ fragments. Crystallization and Data Collection—Diffraction-quality crystals were obtained from 20% polyethylene glycol 6000, in 0.1 m HEPES buffer, pH 7.5, at a protein concentration of 7.9 mg/ml. Protein and precipitant solutions were mixed at the 3:2 ratio, and droplets were allowed to vapor diffuse against wells of precipitant solutions in hanging droplets. Fab′ fragments were crystallized in the orthorhombic space group P212121 having unit-cell dimensions a = 75.05 Å, b = 76.89 Å, c = 82.18 Å, α = β = γ = 90° and one Fab′ molecule in the asymmetric unit. Diffraction data to 2.50 Å resolution were collected with a crystal flash frozen in liquid nitrogen on a R-AXIS IV area detector equipped with a rotating anode x-ray source (93,266 measured intensities, 17,003 unique reflections, 99.9% complete, intensity/σ (intensity) = 4.2 in the highest resolution shell, Rmerge = 0.067). Structure Solution and Refinement of the Model of Anti-id mAb MK2-23 Fab′ Fragments—The three-dimensional structure of the mAb MK2-23 Fab′ fragments was determined by the molecular replacement method using a known Fab structure (Protein Data Bank (PDB) code 2RCS) as the search model and XPLOR routines (22Brünger A.T. X-PLOR: A System for X-ray Crystallography and NMR. 1992; (Yale University Press, New Haven, CT)Google Scholar). The experimentally determined sequences for the variable domains were built into the electron density, and the model was subjected to several rounds of refinement and rebuilding using the CNS package of software (23Brünger A.T. Adams P.D. Clore G.M. DeLano W.L. Gross P. Grosse-Kunstleve R.W. Jiang J-S. Kuszewski J. Nilges M. Pannu N.S. Read R.J. Rice L.M. Simonson T. Warren G.L. Acta Crystallogr. Sect. D Biol Crystallogr. 1998; 54: 905-921Crossref PubMed Scopus (16919) Google Scholar). The final crystallographic R factor for 441 residues and 66 water molecules (3444 total atoms) is 0.236 with an R-free value of 0.297 for 16,656 reflections between 33 and 2.50 Å resolution. TABLE ONE provides a summary of data collection and structure refinement results.TABLE ONEData collection and refinement summaryTotal reflections measured (CuKα radiation, γ = 1.5418 Å)93,465Unique number of reflections17,003Resolution range33-2.50 ÅIntensity/σ (intensity) in the highest shell (2.59-2.50 Å)4.2Percent of possible reflections measured (highest shell)99.7 (99.8)Rmerge (intensity) (highest shell)0.067 (0.327)Non-hydrogen protein atmos in the model (441 amino acids: 217 in L and 224 in H)3378Solvent water oxygen atoms included66Unique reflections used for refinement16,656(Percent of possible)(98%)Crystallographic R-factor0.236Free R-value0.297(Free R test set size)(4.9%)r.m.s.d. from ideal values:Bond length (Å)0.007Bond angle (°)1.5Dihedral angle (°)26.8Estimated coordinate error:From Luzzati plot (Å)0.34From SIGMAA (Å)0.31Temperature factor (B) from Wilson plot (Å2)45.8Mean atomic B factor (Å2)35.6Ramachandran plot:Non-glycine and non-proline residues379Residues in the allowed ranges377Residues in the disallowed ranges2 Open table in a new tab Purification and Biotinylation of mAb 763.74—mAb 763.74 was purified from ascitic fluid by sequential ammonium sulfate and caprylic acid precipitation (24Temponi M. Kageshita T. Perosa F. Ono R. Okada H. Ferrone S. Hybridoma. 1989; 8: 85-95Crossref PubMed Scopus (124) Google Scholar). The purity and activity of mAb preparations were assessed by SDS-PAGE and by testing with the corresponding antigen in a binding assay, respectively. Biotinylation was performed using NHS-LC-biotin (succinimidyl-6-(biotinamido)hexanoate) (Pierce) according to the manufacturer's instructions. Assessment of Peptide PMK2-23H3 Antigenicity—Synthetic peptides derived from anti-id mAb MK2-23CDR3H (PMK2-23H3, ARSNYV-GYHVRWYFD), anti-id mAb MK2-23CDR1L (PMK2-23L1, SVEYYGSSLMQ), and HMW-MAA (PHMW-MAA.D2.7, IRSG-DEVHYHVTAGPRW) were purchased from N. C. Wang, Hospital for Sick Children, Toronto, Ontario, Canada. A synthetic peptide derived from β2-microglobulin (Pb2m, KNGERIEKVEHS), used as a negative control, was purchased from University of Georgia Molecular Genetics Instrumentation Facility (Athens, GA). Escalating concentrations of peptides as indicated were incubated with biotinylated mAb 763.74 (0.5 mg/ml) at 4 °C overnight in U-bottom 96-well plates. The mixture was then incubated with HMW-MAA-bearing melanoma cells Colo38 (105/well) for 1 h at 4 °C. After three washes with 1% bovine serum albumin in phosphate-buffered saline, an optimal amount of horseradish peroxidase-conjugated streptavidin was added. Reactions were then developed and visualized with the 3,3′,5,5′-tetramethylbenzidine substrate system (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD). Reactions were reported as OD measured with an ELISA reader. Percent inhibition was calculated by the formula: 100% × (ODirrelevant peptide - ODtest peptide)/ODirrelevant peptide. Dissociation constant (Kd) was calculated as the molar concentration of the peptide required to cause a 50% inhibition of binding of biotinylated mAb 763.74 to HMW-MAA-bearing melanoma cells Colo38 (25Temponi M. Gold A.M. Ferrone S. Cancer Res. 1992; 52: 2497-2503PubMed Google Scholar). Assessment of Peptide PMK2-23H3 Immunogenicity—Peptide PMK2-23H3 conjugated to the carrier protein keyhole limpet hemocyanin with the cross-linking agent m-maleimidobenzoyl-N-hydroxysuccinimide ester (Pierce) was mixed with complete Freund adjuvant for priming (100 μg/injection) and with incomplete Freund adjuvant for boosting (50 μg/injection). Immunizations were given subcutaneously to 8-week-old female BALB/c mice (Taconic Farms, Germantown, NY) (five per group) on days 0, 21, and 42. Sera were harvested before immunization and on days 7 and 28. They were tested for reactivity with the immunizing peptide coated on 96-well plates (24Temponi M. Kageshita T. Perosa F. Ono R. Okada H. Ferrone S. Hybridoma. 1989; 8: 85-95Crossref PubMed Scopus (124) Google Scholar) and with HMW-MAA-bearing melanoma cells in ELISA and fluorescence-activated cell sorting (FACS) analysis, as described previously (14Chen Z.J. Yang H. Ferrone S. J. Immunol. 1991; 147: 1082-1090PubMed Google Scholar, 26Luo W. Hsu J.C. Tsao C.Y. Ko E. Wang X. Ferrone S. J. Immunol. 2005; 174: 7104-7110Crossref PubMed Scopus (21) Google Scholar). Amino Acid (aa) Sequence Homology and Structural Similarity of Anti-id mAb MK2-23 CDRs with HMW-MAA Core Protein—To investigate whether aa sequence homology plays a role in the HMW-MAA mimicry by anti-id mAb MK2-23, we compared the aa sequence of the anti-id mAb MK2-23 CDRs with that of the HMW-MAA core protein (27Pluschke G. Vanek M. Evans A. Dittmar T. Schmid P. Itin P. Filardo E.J. Reisfeld R.A. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 9710-9715Crossref PubMed Scopus (134) Google Scholar), since CDRs constitute the idiotope of an antibody. Only a partial homology was found between the CDR3H (H3) and the HMW-MAA core protein (Fig. 1 and data not shown). This region corresponds to residues 94-102 within anti-id mAb MK2-23 H3, displaying eight identical, although discontinuous, and one conservative matches with the region spanning from residues 1159 to 1174 in the HMW-MAA core protein. In addition, the region corresponding to residues 29-33 within anti-id mAb MK2-23 L1 shows four identical and one conservative matches with residues 1132-1136 of the HMW-MAA core protein (Fig. 1). Interestingly, the two homologous regions map, with only 21 aa apart, to the seventh of the 15 putative chondroitin sulfate proteoglycan (CSPG) repeat units of the domain 2 of HMW-MAA (designated HMW-MAA.D2.7, residues 1128-1216) (Fig. 1) (28Staub E. Hinzmann B. Rosenthal A. FEBS Lett. 2002; 527: 114-118Crossref PubMed Scopus (34) Google Scholar). The HMW-MAA.D2.7 segment is predicted to adopt an all-β-fold conformation, comprising eight β-strands (28Staub E. Hinzmann B. Rosenthal A. FEBS Lett. 2002; 527: 114-118Crossref PubMed Scopus (34) Google Scholar). This prediction is supported by the alignment of the putative HMW-MAA.D2.7 β-strands to the six β-strands of a N-cadherin fragment with a known three-dimensional structure (PDB code 1NCJ). Interestingly, the two HMW-MAA.D2.7 regions (residues 1132-1135 and residues 1159-1174), with which anti-id mAb MK2-23 L1 and H3 have homology, are located within the predicted first and fourth β-strands, respectively, in the HMW-MAA segment (Fig. 1) (28Staub E. Hinzmann B. Rosenthal A. FEBS Lett. 2002; 527: 114-118Crossref PubMed Scopus (34) Google Scholar). This observation suggests that the anti-id mAb MK2-23 L1 and H3 loops represent the moiety that mimics the HMW-MAA epitope. Overall Three-dimensional Structure of Anti-id mAb MK2-23 Fab′ Fragments—To determine whether anti-id mAb MK2-23 L1 and H3 loops display a structural fold similar to that of the HMW-MAA.D2.7 segment, we crystallized and solved the structure of the anti-id mAb MK2-23 Fab′ fragments. The overall structure of anti-id mAb MK2-23 Fab′ fragment exhibits the typical immunoglobulin fold with 377 of 379 non-Gly and non-Pro residues in the allowed regions (Fig. 2A and TABLE ONE). The two residues that are in the disallowed region are Ala51 of the L chain and Ser172 of the H chain, both of which are located on turns with well defined electron densities. Our experimental electron densities agree well with the deduced aa sequences of anti-id mAb MK2-23 Fab′ L and H chains, except for the following discrepancies. An Ala side chain was better accommodated than an Arg at residue 71 of the H chain. A few solvent-exposed side chains, such as Tyr100 and Arg100C of the H chain (on the H3 loop), did not show appreciable electron densities. It is likely that these side chains participate in antigen recognition and are dynamically disordered in absence of an antigen. Secondary and Tertiary Conformations of Anti-id mAb MK2-23 L1 and H3—Next we examined the structural features of L1 and H3 loops of the anti-id mAb MK2-23. L1 consists of residues Arg24, Ala25, Ser26, Glu27, Ser27A, Val27B, Glu27C, Tyr27D, Tyr28, Gly29, Ser30, Ser31, Leu32, Met33, and Gln34 (29Kabat E.A. Wu T.T. Perry H.M. Gottesman K.S. Foeller C. Sequences of Proteins of Immunological Interest. 1991; (5th Ed., Public Health Service, National Institutes of Health, Washington, D. C.)Google Scholar). According to current classifications (30Al-Lazikani B. Lesk A.M. Chothia C. J. Mol. Biol. 1997; 273: 927-948Crossref PubMed Scopus (578) Google Scholar), anti-id mAb MK2-23 L1 belongs to the Vk L1 canonical structure 5, containing four insertions. An interesting feature of this L1 loop is the formation of a pair of anti-parallel strands linked by three inter-strand hydrogen bonds (27BCO-HN32, 27DNH-OC30, and 27DCO-HN30) and a left-handed hairpin turn having Tyr28 and Gly29 backbones in the (+,+) helical conformational space of the Ramachandran plot. Whether the latter geometry is a common feature among all canonical structure 5 L1 loops or a unique characteristic of anti-id mAb MK2-23 L1 remains to be determined, since the three-dimensional structure of at least another canonical structure 5 L1 loop is not yet available at the time of preparation of this manuscript (30Al-Lazikani B. Lesk A.M. Chothia C. J. Mol. Biol. 1997; 273: 927-948Crossref PubMed Scopus (578) Google Scholar). Of note here is that the average temperature factor for L1 is about 45 Å2, which is significantly higher than the average temperature factor of the entire molecule (36 Å2). The H3 loop, consisting of residues Ser95, Asn96, Tyr97, Val98, Gly99, Tyr100, His100A, Val100B, Arg100C, Trp100D, Tyr100E, Phe100F, Asp101, and Val102, contains six insertions (29Kabat E.A. Wu T.T. Perry H.M. Gottesman K.S. Foeller C. Sequences of Proteins of Immunological Interest. 1991; (5th Ed., Public Health Service, National Institutes of Health, Washington, D. C.)Google Scholar). H3 is relatively longer than that of other mouse immunoglobulins; it is only shorter than that of mAb R19.9 (PDB code 1FAI) and mAb R45-45-11 (PDB code 1IKF) by 1 and 3 residues, respectively. In accordance with the structural patterns of the immunoglobulin H3 loop torso region (31Morea V. Tramontano A. Rustici M. Chothia C. Lesk A.M. J. Mol. Biol. 1998; 275: 269-294Crossref PubMed Scopus (301) Google Scholar), anti-id mAb MK2-23 H3 belongs to a class in which the torso region does not contain a β-bulge, which is the most common class, but a regular β-sheet hairpin structure (31Morea V. Tramontano A. Rustici M. Chothia C. Lesk A.M. J. Mol. Biol. 1998; 275: 269-294Crossref PubMed Scopus (301) Google Scholar). The salt bridge between Arg94 and Asp101 is absent, but like in most immunoglobulins, the combination of the length and sequence of the loop between Arg94 and Asp101 dictates to a large extent the specificity. The anti-parallel strands at the loop termini are held by hydrogen bonding (95CO-HN101, 96NH—OC100E, 96CO-HN100E, and 98NH-OC100C). At the tip of the loop, residues Tyr100 to Arg100C form a distorted type III helical turn with a 100CO-HN100C hydrogen bond. Similar to L1, H3 also displays high thermal motion (average B ∼60 Å2); however, the main chain and most of the side chain electron densities, except those of Tyr97 and Arg100C, are well defined to allow an unequivocal tracing of the backbone. It is noteworthy that the L1 and H3 loops pack closely against each other through hydrophobic interactions (L1 Leu32 side chain against the H3 main chain, Val106 and Tyr27D side chains) and through the formation of one hydrogen bond (L1 Gln34 to H3 Trp100D CO). Comparison of L1 and H3 Loops of Anti-id mAb MK2-23 with Those of Other Anti-id mAb—To examine the structural variation of the anti-id mAb MK2-23 L1 and H3 loops as compared with other anti-id antibodies, we aligned the three-dimensional structure of these two loops with those of the four anti-id mAb structures available thus far: 409.5.3 (PDB code 1AIF), 6A6 (PDB code 1PG7), E225 (PDB code 1CIC), and E5.2 (PDB code 1DVF). Two anti-anti-id mAb, 131 (PDB code 2CK0) and GH1002 (PDB code 1GHF), and two idiotypic mAb, Mopc21 (PDB code 1IGC) and R24 (PDB code 1R24), were used for comparison. Using least squares fitting, the loop termini, which correspond to the conserved residues 23 and 37 of the L chain and 91 and 106 of the H chain, superimpose well with root mean square deviations (r.m.s.d.) between 0.2 and 1 Å (Fig. 3). Between the termini, the loops, and especially H3, adopt varying conformations with the largest r.m.s.d. around 6.5 Å. The H3 loop of anti-id mAb MK2-23 is long and forms a pair of anti-parallel β-strands linked by four hydrogen bonds (Figs. 2B and 3). Together with the L1 loop, the H3 loop of anti-id mAb MK2-23 projects a 41-residue-long surface, which is the most protruded among all the anti-id antibodies with a known three-dimensional structure. Similarity in the in Vitro Reactivity of the Anti-id mAb MK2-23-derived Peptide PMK2-23H3 and of the HMW-MAA.D2.7-derived Peptide PHMW.D2.7—The peptide ARSNYVGYHVRWYFD (designated as PMK2-23H3), which was derived from the H3 loop of anti-id mAb MK2-23 encompassing the described HMW-MAA-homologous aa sequence, was synthesized and analyzed for reactivity with the HMW-MAA-specific idiotypic mAb 763.74. As shown in Fig. 4, peptide PMK2-23H3 inhibits the binding of mAb 763.74 to HMW-MAA-bearing melanoma cells to a similar extent as the HMW-MAA.D2.7-derived peptide (IRSGDEVHYHVTAGPRW, designated as PHMW.D2.7). The inhibition is specific, since the irrelevant peptide Pb2m had no detectable effect on the binding of mAb 763.74 to melanoma cells. The Kd values for peptides PMK2-23H3 and PHMW.D.2.7 are 871 and 900 nm, respectively. The peptide SVEYYGSSLMQ (designated as PMK2-23L1), which was derived from the L1 loop of anti-id mAb MK2-23 encompassing the described HMW-MAA-homologous aa sequence, was also synthesized. Because of its low solubility, peptide PMK2-23L1 could not be used alone or in combination with peptide PMK2-23H3 in peptide binding assays. HMW-MAA-like Immunogenicity of the Anti-id mAb MK2-23-derived Peptide PMK2-23H3—Anti-id mAb MK2-23H3-derived peptide PMK2-23H3 elicited in BALB/c mice antibodies that reacted with the immunizing peptide, with the HMW-MAA-derived peptide PHMW.D2.7 and with anti-id mAb MK2-23, as measured in a peptide binding assay (Fig. 5A). The elicited antibody response is specific, since the sera from the mice immunized with the irrelevant peptide Pb2m displayed no detectable reactivity with peptides PMK2-23H3 and PHMW.D2.7. More importantly, peptide PMK2-23H3 elicited in BALB/c mice antibodies with selective reactivity with HMW-MAA-bearing cells. As shown in Fig. 5B, sera from peptide PMK2-23H3-immunized mice reacted with HMW-MAA-transfected M14 melanoma cells (M14.HMW-MAA) but did not react with the mock-transfected counterpart (M14.neo) both in ELISA and in FACS analysis. The crystal structure of the anti-id mAb MK2-23 Fab′ fragments revealed distinctive features of the three-dimensional conformations of CDR loops L1 and H3, strongly suggesting that the two loops play important roles in the interaction with mAb 763.74 and in the mimicry of the HMW-MAA epitope defined by mAb 763.74. Interestingly, when compared with H3 loops of anti-id mAb 409.5.3 (PDB code 1AIF), 6A6 (PDB code 1PG7), E225 (PDB code 1CIC), and E5.2 (PDB code 1DVF) with known three-dimensional structures, anti-id mAb MK2-23 L1 and H3 appear to be more protruded, displaying large variations in conformations. Of note is the left-handed hairpin turn present in L1 and a pair of anti-parallel β-strands with strong interstrand hydrogen-bonding present in H3. These findings are in agreement with the predicted structure of the corresponding HMW-MAA.D2.7 fragment, which may also adopt a similar β-strand conformation (28Staub E. Hinzmann B. Rosenthal A. FEBS Lett. 2002; 527: 114-118Crossref PubMed Scopus (34) Google Scholar). Several lines of evidence indicate the involvement of the anti-id mAb MK2-23 H3 loop (and perhaps also of the L1 loop) in the HMW-MAA mimicry by anti-id mAb MK2-23. First, the two loops exhibit moderate aa sequence homology with the HMW-MAA core protein, and the homologous regions are located in the same CSPG repeat unit (aa 1128-1216) only 21 residues apart. Supported by secondary structure prediction, these two HMW-MAA regions may be spatially close to form the epitope recognized by the HMW-MAA-specific mAb 763.74. Second, the anti-id mAb MK2-23H3-derived peptide PMK2-23H3 inhibits the binding of mAb 763.74 to HMW-MAA-bearing cells to the same extent as the corresponding HMW-MAA-derived peptide PHMW.D2.7. Last, peptide PMK2-23H3 elicited HMW-MAA-specific antibodies in BALB/c mice which express the antigen AN2. The latter displays at least 80% homology with HMW-MAA. These results imply that the peptide PMK2-23H3 is able to break unresponsiveness to a self-tumor antigen. The role of the anti-id mAb MK2-23 L1 loop could not be tested in this study because of the low solubility of the synthesized peptide. Whether the L1 loop is part of the scaffold that helps form the HMW-MAA-mimicking moiety remains to be determined. Taken together, these results support the role of a 15-residue motif of the anti-id mAb MK2-23 H3 loop in the structural basis of HMW-MAA mimicry by the anti-id mAb MK2-23. The role of the H3 loop of anti-id antibodies in antigen mimicry has been reported in other antigenic systems. Fields et al. (32Fields B.A. Goldbaum F.A. Ysern X. Poljak R.J. Mariuzza R.A. Nature. 1995; 374: 739-742Crossref PubMed Scopus (162) Google Scholar) have shown that in a hen egg lysozyme system the anti-id mAb VH3 accounts for 77% of the interaction with the idiotypic antibody. Furthermore, Ban et al. (33Ban N. Escobar C. Garcia R. Hasel K. Day J. Greenwood A. McPherson A. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 1604-1608Crossref PubMed Scopus (89) Google Scholar) have demonstrated that in the feline infectious peritonitis virus E2 peplomer system the anti-id mAb VH constitutes 63% of the binding interface with the idiotypic antibody. Notably, in these systems the anti-id antibodies were found to represent the mirror images of their nominal antigens, because they are both structurally and functionally similar to the nominal antigen, i.e. they are able to elicit antigen-binding, anti-anti-id antibodies. Whether this structural organization of the idiotypic cascade is a general rule or is restricted to some antigenic system remains to be determined. From a practical viewpoint, the identification of a single peptide loop as an important structure-mimicking element allows us to investigate the relationship between the degree of antigen mimicry by a peptide mimic and its ability to overcome unresponsiveness to the nominal self-antigen. In the case of anti-id mAb MK2-23, the 15-residue H3 loop is a partial β-strand and is self-stabilized by 4 interchain hydrogen bonds, suggesting that the anti-id mAb MK2-23 H3 loop is quite stable in solution. This feature will facilitate introduction of aa substitutions into the loop to modulate its structure and functional properties. It is tempting to speculate that subtle changes in the structural property of the H3 loop may change its ability to induce nominal antigen-specific immune response. This possibility is supported by the finding that the isoaspartyl form of a cytochrome c peptide but not its nominal (aspartyl) counterpart can break humoral tolerance to the self-cytochrome c (34Mamula M.J. Gee R.J. Elliott J.I. Sette A. Southwood S. Jones P.J. Blier P.R. J. Biol. Chem. 1999; 274: 22321-22327Abstract Full Text Full Text PDF PubMed Scopus (175) Google Scholar)." @default.
• W2002731775 created "2016-06-24" @default.
• W2002731775 creator A5023454962 @default.
• W2002731775 creator A5028669896 @default.
• W2002731775 creator A5032986788 @default.
• W2002731775 creator A5073349983 @default.
• W2002731775 creator A5086232005 @default.
• W2002731775 creator A5089311549 @default.
• W2002731775 date "2005-12-01" @default.
• W2002731775 modified "2023-10-17" @default.
• W2002731775 title "Structural Basis of Antigen Mimicry in a Clinically Relevant Melanoma Antigen System" @default.
• W2002731775 cites W1510526370 @default.
• W2002731775 cites W1946541909 @default.
• W2002731775 cites W1950483962 @default.
• W2002731775 cites W1981295860 @default.
• W2002731775 cites W1995017064 @default.
• W2002731775 cites W1997481878 @default.
• W2002731775 cites W1998268789 @default.
• W2002731775 cites W2008943339 @default.
• W2002731775 cites W2009642161 @default.
• W2002731775 cites W2018027744 @default.
• W2002731775 cites W2031120162 @default.
• W2002731775 cites W2033099131 @default.
• W2002731775 cites W2042848281 @default.
• W2002731775 cites W2044557797 @default.
• W2002731775 cites W2054587629 @default.
• W2002731775 cites W2056433388 @default.
• W2002731775 cites W2063366729 @default.
• W2002731775 cites W2073245859 @default.
• W2002731775 cites W2073871857 @default.
• W2002731775 cites W2083047040 @default.
• W2002731775 cites W2093037100 @default.
• W2002731775 cites W2143467722 @default.
• W2002731775 cites W2149123553 @default.
• W2002731775 cites W2167795220 @default.
• W2002731775 cites W2419328364 @default.
• W2002731775 doi "https://doi.org/10.1074/jbc.m507562200" @default.
• W2002731775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16227204" @default.
• W2002731775 hasPublicationYear "2005" @default.
• W2002731775 type Work @default.
• W2002731775 sameAs 2002731775 @default.
• W2002731775 citedByCount "18" @default.
• W2002731775 countsByYear W20027317752012 @default.
• W2002731775 countsByYear W20027317752014 @default.
• W2002731775 countsByYear W20027317752015 @default.
• W2002731775 countsByYear W20027317752016 @default.
• W2002731775 countsByYear W20027317752017 @default.
• W2002731775 countsByYear W20027317752019 @default.
• W2002731775 crossrefType "journal-article" @default.
• W2002731775 hasAuthorship W2002731775A5023454962 @default.
• W2002731775 hasAuthorship W2002731775A5028669896 @default.
• W2002731775 hasAuthorship W2002731775A5032986788 @default.
• W2002731775 hasAuthorship W2002731775A5073349983 @default.
• W2002731775 hasAuthorship W2002731775A5086232005 @default.
• W2002731775 hasAuthorship W2002731775A5089311549 @default.
• W2002731775 hasBestOaLocation W20027317751 @default.
• W2002731775 hasConcept C147483822 @default.
• W2002731775 hasConcept C203014093 @default.
• W2002731775 hasConcept C2777119779 @default.
• W2002731775 hasConcept C7863114 @default.
• W2002731775 hasConcept C86803240 @default.
• W2002731775 hasConcept C90856448 @default.
• W2002731775 hasConceptScore W2002731775C147483822 @default.
• W2002731775 hasConceptScore W2002731775C203014093 @default.
• W2002731775 hasConceptScore W2002731775C2777119779 @default.
• W2002731775 hasConceptScore W2002731775C7863114 @default.
• W2002731775 hasConceptScore W2002731775C86803240 @default.
• W2002731775 hasConceptScore W2002731775C90856448 @default.
• W2002731775 hasIssue "50" @default.
• W2002731775 hasLocation W20027317751 @default.
• W2002731775 hasOpenAccess W2002731775 @default.
• W2002731775 hasPrimaryLocation W20027317751 @default.
• W2002731775 hasRelatedWork W2042815515 @default.
• W2002731775 hasRelatedWork W2055509168 @default.
• W2002731775 hasRelatedWork W2080835595 @default.
• W2002731775 hasRelatedWork W2081926413 @default.
• W2002731775 hasRelatedWork W2082860237 @default.
• W2002731775 hasRelatedWork W2087230009 @default.
• W2002731775 hasRelatedWork W2096139282 @default.
• W2002731775 hasRelatedWork W2159218316 @default.
• W2002731775 hasRelatedWork W2414745257 @default.
• W2002731775 hasRelatedWork W2566749067 @default.
• W2002731775 hasVolume "280" @default.
• W2002731775 isParatext "false" @default.
• W2002731775 isRetracted "false" @default.
• W2002731775 magId "2002731775" @default.
• W2002731775 workType "article" @default.